A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151679 Peptide for use in the treatment of infections, viral and cancer diseases
10/17/2002	US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002	US20020151676 Streptogramin derivatives, preparation method and compositions containing same
10/17/2002	US20020151650 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/17/2002	US20020151646 Comprises glutamic acid, sodium glutamate, or glycine; for measurement of coagulation factor; sensitivity; blood screening; freeze-drying
10/17/2002	US20020151592 Long term administration of L-arginine, L-lysine or salts, and a polypeptide precursor which enhance the level of endogenous nitric oxide or intermediates in the NO induced relaxation pathway in the host
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151551 Use of growth hormone secretagogues in conjunction with physical exercise cross reference to related application
10/17/2002	US20020151546 HIV protease inhibitors based on amino acid derivatives
10/17/2002	US20020151538 Azepin-2-one derivatives useful for treating Alzheimer's disease
10/17/2002	US20020151536 Substituted azetidinone is used as sterol absorption inhibitor and a fibric acid derivative selected from fenofibrate, clofibrate, gemfibrozil, ciprofibrate, bezafibrate, clinofibrate etc
10/17/2002	US20020151531 Administering to a female of child bearing age over a period of 28 consecutive days a first phase of from 18 to 21 daily dosage units of a progestational agent, and a second phase of from 1 to 7 daily dosage units of an antiprogestin agent
10/17/2002	US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002	US20020151526 Bile-acid conjugates useful for sustained release of L-DOPA, inhibitors of catechol O-methyl transferase and/or inhibitors of L-aromatic amino acid decarboxylase
10/17/2002	US20020151522 Regulation of weight
10/17/2002	US20020151521 Packaged condomes containing spermicides, microbiocides and viricides, an acid buffer solution, a wound healing and diffusion impedance compound selected from dextran sulfate, chondroitin sulfate, pentosan polysulfate and a hyaluronate
10/17/2002	US20020151518 Oligonucleotide mediated specific sytokine induction and reduction of tumor growth in a mammal
10/17/2002	US20020151517 Administering to the mammal nucleosomes(a complex of DNA and histones) that elicit the production of antinuclear autoantibodies sufficient to inhibit neoplastic cell growth
10/17/2002	US20020151516 Carrier:nucleic acids complexes containing nucleic acids encoding anti-angiogenic peptides and their use in gene therapy
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151513 Localized oligonucleotide therapy for preventing restenosis
10/17/2002	US20020151512 Used to diagnose or treat cancer, restenosis, a disease caused by a virus, a disease affected by integrins or cell-cell adhesion receptor or a disease triggered by diffusible factors
10/17/2002	US20020151511 Antisense oligonucleotide modulation of human MDM2 expression
10/17/2002	US20020151510 Methods and compositions for the treatment of human immunodeficiency virus infection
10/17/2002	US20020151509 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver
10/17/2002	US20020151504 Amino acid containing compounds useful as modulators of the immune system
10/17/2002	US20020151503 Methods of cancer treatment using naaladase inhibitors
10/17/2002	US20020151502 Manufactured peptide having formula pGlu-R1-Pro, wherein R1 is Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof
10/17/2002	US20020151501 Compounds having growth hormone releasing activity
10/17/2002	US20020151500 Administering a therapeutically effective amount of a type-5 selective somatostatin agonist to patient
10/17/2002	US20020151499 Using histacalin protein isolated from ticks
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151497 Inhibitors comprise sequences derived from specific regions of the Lyn-kinase
10/17/2002	US20020151496 Treatment of spinal cord damage, spinal cord trauma, neuronal tissue damage produced by ischemic attack
10/17/2002	US20020151495 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of glucose-dependent insulinotropic polypeptide
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151493 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
10/17/2002	US20020151491 Uses MUC5AC plasmid to identify cytoplasmic proteins of Nontypeable Haemophilus influenzae, a mediator of otitis media and chronic obstructive pulmonary disease, which up-regulates human mucin transcription
10/17/2002	US20020151490 Administering a complex comprising an insulin-like growth factor (IGFII) and an insulin-like growth factor binding protein (IGFBP2) polypeptide to increase bone mass or ameliorating loss of bone mass; bone disorders
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151487 Method and reagents for epithelial barrier formation and treatment of malignant and benign skin disorders by modulating the notch pathway
10/17/2002	US20020151486 Stimulating and modulating bone cell differentiation and bone formation; bone disorders including osteopetrosis and osteoporosis; genetic engineeing; gene therapy;
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151482 Administering to a bird or mammal a PRG-B polypeptide as an angiogenesis inhibitor; antitumor, -carcinogenic, -neoplastic and -arthritic agents; diabetic retinopathy; cancer of the lung, breast, or prostate gland; gene therapy
10/17/2002	US20020151481 MMP-2 propeptide for use as antiangiogenic or antitumor agent
10/17/2002	US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002	US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151475 Compounds and methods for modulating cell adhesion
10/17/2002	US20020151474 Processes for making pharmaceutical oral ECB formulations and compositions
10/17/2002	US20020151473 Constrained helical peptides and methods of making same
10/17/2002	US20020151472 Trefoil factor (TFF) peptides (tricyclic peptides, e.g., TFF2 peptides), for increasing the viscosity of mucus layers; used for treating damaged or abnormal mucus layers, e.g. in the gastrointestinal tract, respiratory/urogential systems, eyes
10/17/2002	US20020151471 Factor VII glycoforms
10/17/2002	US20020151470 Inhibitors of phospholipase A2
10/17/2002	US20020151469 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151468 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151467 Methods and compositions for oral insulin delivery
10/17/2002	US20020151465 Decrease hyperalgesia, without impairing nociception
10/17/2002	US20020151464 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
10/17/2002	US20020151461 Modified retinoblastoma tumor supressor proteins
10/17/2002	US20020151460 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/17/2002	US20020151458 Method for treating and preventing septic shock with VPAC1R, VPAC2R and PAC1R agonists
10/17/2002	US20020151457 FRA -1 expression in brain cancer
10/17/2002	US20020151073 Transcription factor
10/17/2002	US20020151063 Controlling apoptosis in cells; obtain cells, incubate with modulator, monitor transcriptional activity and apoptosis
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151030 Protein for use in the treatment and prevention of cell proliferative disorders
10/17/2002	US20020151028 Structure-based drug design for Ulp1 protease substrates
10/17/2002	US20020151027 Viral fiber protein for use in the treatment of viral diseases
10/17/2002	US20020151025 Human TSC403 gene and human ING1L gene
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151020 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/17/2002	US20020151016 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020151007 Nucleotide seauemces coding enzymatic polypeptide for use in the treatment, prevention of tumor
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150992 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
10/17/2002	US20020150991 Polypeptide for use the treatment of glycogen defects
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002	US20020150981 Methods for producing highly phosphorylated lysosomal hydrolases
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150975 Peptide for use the treatment of cancer
10/17/2002	US20020150971 Nucleic acids and polypeptides for controlling food intake and/or body weight
10/17/2002	US20020150970 Galectin 8,9,10 and 10sv
10/17/2002	US20020150964 Peptides for the activation of the immune system in humans and animals
10/17/2002	US20020150963 Map
10/17/2002	US20020150958 Detecting modulator of inflammation; obtain enzyme sample, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicate modulator
10/17/2002	US20020150956 Novel tig
10/17/2002	US20020150954 Detecting modulators of tumor suppressor gene activity; obtain cells, incubate with modulator, detec adjustment of gene expression from tumor suppressor gene, adjustment in activity indicates modulator

1 ... 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 ... 3163